Quest Diagnostics (DGX) Gains from Investment Securities (2016 - 2026)
Quest Diagnostics has reported Gains from Investment Securities over the past 18 years, most recently at $37.0 million for Q1 2026.
- Quarterly results put Gains from Investment Securities at $37.0 million for Q1 2026, up 3600.0% from a year ago — trailing twelve months through Mar 2026 was $81.0 million (up 3950.0% YoY), and the annual figure for FY2025 was $45.0 million, up 87.5%.
- Gains from Investment Securities reached $37.0 million in Q1 2026 per DGX's latest filing, up from $25.0 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $55.0 million in Q3 2024 and bottomed at -$60.0 million in Q2 2022.
- Median Gains from Investment Securities over the past 5 years was $3.0 million (2023), compared with a mean of $4.5 million.
- The largest annual shift saw Gains from Investment Securities tumbled 1900.0% in 2024 before it soared 3600.0% in 2026.
- Over 5 years, Gains from Investment Securities stood at -$29.0 million in 2022, then soared by 196.55% to $28.0 million in 2023, then soared by 96.43% to $55.0 million in 2024, then crashed by 54.55% to $25.0 million in 2025, then soared by 48.0% to $37.0 million in 2026.
- Business Quant data shows Gains from Investment Securities for DGX at $37.0 million in Q1 2026, $25.0 million in Q4 2025, and -$22.0 million in Q3 2025.